- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04445740
The i Heart Rhythm Project: Healthy Sleep and Behavioral Rhythms for Obesity Prevention
October 23, 2023 updated by: Jennette P. Moreno, Baylor College of Medicine
Feasibility, Acceptability, and Preliminary Efficacy of the i Heart Rhythm Project
This pilot study will examine the feasibility, acceptability, and preliminary efficacy of the intervention.
This will ensure that all aspects of the research protocol and procedures work as desired and are acceptable to families in preparation for the fully powered randomized controlled trial.
The proposed study will assess our ability to: 1)recruit, consent, and retain participants, 2) deliver the intervention, 3) implement study and assessment procedures 4) assess the reliability of the proposed measures in this sample, 5) determine whether modifications to the intervention, procedures, and measures are needed prior to conducting a fully powered study, and 6) willingness of participants to participate in the intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The current study employs a 2 group randomized control design (treatment and no-treatment control) with randomization occurring after baseline (time 0) and 3 additional evaluation periods (end of intervention (time 1), and 9 months (time 2) and 12 months post intervention (time 3)).
Because the the i♥rhythm project is intended to prevent children from beginning a trajectory toward overweight/obesity in elementary school, the impact of the intervention on change in standardized BMI (BMIz) during the following summer (time 2 and 3) will be explored, identifying whether a maintenance intervention is needed.
Following the intervention and final data assessment (time 1 and 3), qualitative interviews will explore the acceptability of the intervention, treatment barriers and facilitators, difficulties with study procedures, maintenance of improvements, and self-efficacy to maintain improvements.
A third treatment condition controlling for the effect of attention was beyond the scope of the current feasibility study.
Study Type
Interventional
Enrollment (Actual)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Children's Nutrition Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 60 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- The index child is 5-8 years old and currently enrolled in kindergarten, first, or second grade
- Parent reports being a daily user of social media
- Parent willing to engage in an mobile health intervention that includes social media
- Parent owns a smart phone
- At least 1 parent is comfortable participating in the intervention and responding to questionnaires in English
- Index child has a BMI >50th percentile
- families live in the greater Houston area and able to attend in-person data collection at the Children's Nutrition Research Center.
Exclusion Criteria:
- Per parent report, the child does not have a chronic medical condition affecting sleep, eating behaviors, weight status, or behavioral rhythms (e.g., obstructive sleep apnea, attention deficit hyperactivity disorder, autism). The inclusion and exclusion criteria will be assessed using a screening questionnaire and assessments which will be administered following the consenting procedures.
- Per parent report, the child is not being treated with a medication or supplement known to affect sleep.
- Child has not participated in an obesity prevention or obesity treatment program in the last 6 months
- Child had not been retaine 2 or more grades for academic reason or has intellectual difficulities that would influence their ability to complet questionnaires or participate in interviews.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Participants will receive an intervention and will participate in assessments
|
behavioral mobile health intervention, targeting parents of 5-8 year olds, designed to promote consistent behavioral rhythms in children through consistent bedtimes, light exposure, meal timing, and physical activity.
|
|
No Intervention: Control
Participants will not receive an intervention, but will participate in assessments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility Criteria: ability to recruit the needed sample size
Time Frame: 3 months
|
The feasibility of the intervention will be established by our ability to recruit the needed sample size and retain at least 80% at Time 1 and 60% at Time 3; favorable acceptability ratings by 80% of the sample, participation in greater than 60% of daily diaries, views of intervention materials by 80% of participants.
Decisions regarding changes to the intervention will be made based on the attainment of feasibility criteria and post-assessment interviews.
Decisions regarding changes to the intervention will be made based on the attainment of feasibility criteria and post-assessment interviews.
|
3 months
|
|
Treatment Acceptability
Time Frame: 3 months
|
Treatment Acceptability Report Form-Revised(TARF-R) 185 is a 20-item global measure of treatment acceptability for behavioral interventions.
The TARF-R has demonstrated good internal consistency (αs>.69) and evidence of construct validity.
A favorable rating is considered 4 or greater.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anthropometrics
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Body Mass Index (BMI) is the most common indicator of body size and has been consistently correlated with metabolic problems in children.
Participants' height and weight will be measured using established protocols.
BMI (kg/m2) will be computed and BMI %ile and BMIz will be calculated from age and gender normative data.
BMI %ile will determine weight status group.
Change in BMI and BMIz are the best proxy measures for change in fat mass and standardized fat mass and will assess exploratory hypotheses.
Change in BMI will serve as the primary outcome for the fully powered randomized controlled trial.
For the current application, feasibility criteria will serve as the primary outcome.
|
0 months, 3 months, 12 months and 15 months
|
|
Measurement of endogenous circadian rhythms
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Circadian phase can be examined by measuring the circadian timing of melatonin onset under dim light conditions (dim light melatonin onset; DLMO).
Compared to markers of endogenous circadian rhythms, melatonin is relatively robust.
Salivary DLMO measures have demonstrated high intraclass correlations (.93) with plasma and sensitivity and specificity comparable to plasma assays.
Following established procedures with children, salivary DLMO will be collected on a weekday evening in the laboratory under dim light conditions (<40 lux), via a cheek swab every hour beginning 5 hours prior to and ending 1 hour following typical bedtime.
Saliva samples will be centrifuged, frozen, and assayed using radioimmunoassay test kits.
DLMO phase will be determined using linear interpolation across the time points before and after melatonin concentration increased to and remained above 4pg/mL.
|
0 months, 3 months, 12 months and 15 months
|
|
Actigraphy for the measurement of sleep, sleep/wake patterns, physical activity, and light exposure.
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Actigraphs (GT3X-BT, Pensacola, FL) worn on the wrist of the dominant hand 24 hours a day for 7 days will measure sleep duration and timing of sleep onset and waking.
Wrist placement reliably measures sleep duration in adolescents.
Sleep diaries will be completed.
Monitor-wear logs will identify times the accelerometer is removed and the activity engaged in while the monitor is off.
The photocell contained in the Actigraph GT3X-BT will be used to measure ambient light exposure.
Accelerometers have been extensively used to assess children's physical activity (PA).
Five days of monitoring had 0.8 reliability of accurately capturing the habitual PA of children.
Activity counts captured in 5-second epochs will be categorized into sedentary, light, moderate, and vigorous PA using established cut points.
|
0 months, 3 months, 12 months and 15 months
|
|
Body composition
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Since BMI can misrepresent adiposity among muscular and slender children, use of additional body fat indicators has been recommended.
Investigators will assess percent body fat using Bod Pod.
|
0 months, 3 months, 12 months and 15 months
|
|
Dietary Assessment
Time Frame: 0 months, 3 months, 12 months and 15 months
|
The Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA-24)174 will be used to assess children's dietary intake (e.g., total daily caloric intake, timing of intake, timing of the last eating episode of the day).
As recommended, parents will complete the adult version of the ASA-24, providing proxy report of their child's dietary intake.
Investigators will use 3 days of diet assessment as 3 days optimize the prediction of doubly labeled water estimated energy expenditure.
|
0 months, 3 months, 12 months and 15 months
|
|
Parenting Structure
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Comprehensive General Parenting Questionnaire (CGPQ) is a parent report of parenting practices among parents of 5-13 year olds.
Investigators will assess subscales related to parenting structure (inconsistent discipline, consistency, organization, and scaffolding).
There is support for the construct validity of the CGPQ.
Parenting structure subscales have demonstrated acceptable to good internal reliability (ranging from .67-.74).
Subscale scores range from 5 to 25.
Higher scores indicate higher levels of structure.
|
0 months, 3 months, 12 months and 15 months
|
|
Bedtime Routines
Time Frame: 0 months, 3 months, 12 months and 15 months
|
The Bedtimes Routines Questionnaire (BRQ), is a 31-item parent report measure of children's bedtime routines, comprised of three scales measuring consistency of bedtime routines (weekday & weekend), reactivity to changes in bedtime routines, and frequency of adaptive and maladaptive activities.
The BRQ scales had good internal consistency ranging from α = 0.69 to 0.90.
Scores on the consistency and adaptive behavior subscales range from 10 to 50 with higher scores reflecting more consistent bedtime routines and higher.
The reactivity scale scores range from 5 to 25 with higher scores reflecting greater reactivity.
The maladaptive behavior scale has possible scores ranging from 6 to 30 with higher scores reflecting more maladaptive behaviors.
|
0 months, 3 months, 12 months and 15 months
|
|
Summer Care Arrangements
Time Frame: 0 months, 3 months, 12 months and 15 months
|
How Children Spend their Summer (e.g., children's involvement in summer school, child care, entertainment programs, as well as day or overnight camps) will be assessed by a parent report survey based on a modified version of the Early Childhood Longitudinal Program Kindergarten Class' parent interview on summer activities.
The Girl's Health Enrichment Multisite Studies demographic protocol will be employed with parents.
|
0 months, 3 months, 12 months and 15 months
|
|
Stress (Parent)
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Perceived Stress Scale (PSS-10) is a 10-item self-report measure of perceived stress with established acceptable psychometric properties(α's >.70, test-retest criterion coefficient >.7, validated factor structure and evidence of convergent validity).
Scores range from 0 to 40 with higher scores reflecting higher levels of perceived stress.
|
0 months, 3 months, 12 months and 15 months
|
|
Social Support (Parent)
Time Frame: 0 months, 3 months, 12 months and 15 months
|
Interpersonal Support Evaluation List (ISEL) is a 12-item self-report measure of the perceived availability of social support (i.e.
Tangible, appraisal, and belonging).
The ISEL has demonstrated good reliability.
The "tangible" subscale assesses perceived availability of resources and material aid; the "appraisal" subscale assesses the perceived availability of another individual(s) to discuss one's problems; the "self-esteem" subscale assesses the perceived availability of someone to compare one's self to in a positive manner; and the "belonging" subscale, the perceived availability of having others to socialize and do things with.
Scores range from 0-30 on each scale with greater scores indicating higher levels of social support.
|
0 months, 3 months, 12 months and 15 months
|
|
Motivation to Continue in the Program
Time Frame: 3 months
|
The Treatment Questionnaire Concerning Continued Program Participation was originally developed to assess reasons for continuing to participate in a weight-loss program.
We have adapted it assess reasons for continuing to participate focused on addressing children's sleep during summer.
Scores in the Autonomous Regulation scale range from 5 to 35 and scores on the Controlled Regulation range from 8 to 56.
Higher scores reflect higher levels of Autonomous and Controlled regulation.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jennette Moreno, Baylor College of Medicine
- Study Director: Hafza Dadabhoy, MS, Baylor College of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Moreno JP, Dadabhoy H, Musaad S, Baranowski T, Thompson D, Alfano CA, Crowley SJ. Evaluation of a Circadian Rhythm and Sleep-Focused Mobile Health Intervention for the Prevention of Accelerated Summer Weight Gain Among Elementary School-Age Children: Protocol for a Randomized Controlled Feasibility Study. JMIR Res Protoc. 2022 May 16;11(5):e37002. doi: 10.2196/37002.
- Moreno JP, Hannay KM, Walch O, Dadabhoy H, Christian J, Puyau M, El-Mubasher A, Bacha F, Grant SR, Park RJ, Cheng P. Estimating circadian phase in elementary school children: leveraging advances in physiologically informed models of circadian entrainment and wearable devices. Sleep. 2022 Jun 13;45(6):zsac061. doi: 10.1093/sleep/zsac061.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2021
Primary Completion (Actual)
August 18, 2023
Study Completion (Actual)
August 18, 2023
Study Registration Dates
First Submitted
May 26, 2020
First Submitted That Met QC Criteria
June 23, 2020
First Posted (Actual)
June 24, 2020
Study Record Updates
Last Update Posted (Actual)
October 25, 2023
Last Update Submitted That Met QC Criteria
October 23, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-47369
- R00HD091396 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity Prevention
-
Augusta UniversityEnrolling by invitationObesity PreventionUnited States
-
Amsterdam University Medical Centers (UMC), Location...RecruitingObesity Prevention | Microbiome AnalysisNetherlands
-
Northwell HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPrevention Childhood Obesity | Feasibility and AcceptabilityUnited States
-
Marie HERRCompletedObesity Prevention | Cancer PreventionFrance
-
University of TorontoThe Hospital for Sick Children; Dairy Farmers of CanadaCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International... and other collaboratorsCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International...CompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoIngredion IncorporatedCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoIngredion IncorporatedCompletedDiabetes Prevention | Obesity PreventionCanada
-
Centre d'Etudes et de Documentation du SucreMinistry of Higher Education and Research, France; Paris Academy (Rectorat... and other collaboratorsCompletedPrimary Prevention | Obesity Prevention | Body Weight ControlFrance
Clinical Trials on i♥rhythm project
-
Hanoi Medical UniversityJohns Hopkins University; Fogarty International Center of the National Institute...Not yet recruitingMental Disorder | HIV StigmaVietnam
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedHIV Infections | HIV InfectionBrazil
-
UNICANCERCompletedKRAS Gene Mutation | Infiltrating Urothelial CarcinomaFrance
-
University of Southern CaliforniaPfizerTerminatedColorectal CancerUnited States
-
Chong Kun Dang PharmaceuticalAsan Medical CenterCompleted
-
Washington University School of MedicineCompletedStomach Neoplasms | Esophageal NeoplasmsUnited States
-
ERYtech PharmaCompletedPancreatic AdenocarcinomaUnited States, United Kingdom, France